versartis.com
Versartis, Inc.Versartis, Inc. is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders.
http://www.versartis.com/
Versartis, Inc. is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders.
http://www.versartis.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
0.1 seconds
Versartis, Inc.
Steve Briggs
500 E●●●●●treet
Moun●●●●View , CA, 94043
UNITED STATES
View this contact
Versartis, Inc.
Steve Briggs
500 E●●●●●treet
Moun●●●●View , CA, 94043
UNITED STATES
View this contact
Versartis, Inc.
Steve Briggs
500 E●●●●●treet
Moun●●●●View , CA, 94043
UNITED STATES
View this contact
BUY YOUR DOMAIN
18
YEARS
2
MONTHS
4
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
64
SITE IP
192.220.11.242
LOAD TIME
0.055 sec
SCORE
6.2
Versartis, Inc. | versartis.com Reviews
https://versartis.com
Versartis, Inc. is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders.
Investor Overview - Versartis
Annual Reports and Proxies. Versartis, Inc. is an endocrine-focused biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders. Versartis was founded in December 2008 and is headquartered in Menlo Park, California, USA. 4:00 PM ET on Aug 17, 2015. Delayed at least 20 minutes. Aug 11, 2015. Versartis to Host Investor Symposium Featuring Global Opinion Leaders in Pediatric Human Growth Hormone Deficiency. Aug 4, 2015. View all press releases ». Canaccord ...
versartis.com
Versartis, Inc. - About Versartis
http://www.versartis.com/content/aboutus/overview.htm
Versartis, Inc. is an endocrine-focused biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders. Versartis was founded in December 2008 and is headquartered in Menlo Park, California, USA. Develop, manufacture and commercialize novel medicines to transform treatment for patients with endocrine disorders. New compounds developed by Versartis using the XTEN technology are expected to provide improved therapeutic outcomes such as enhanced efficacy, fewe...
Versartis, Inc. - Product Pipeline
http://www.versartis.com/content/productpipeline/overview.htm
Versartis is interested in exploring partnerships to accelerate the development process and maximize the commercial potential for our products. To learn more about opportunities to partner with Versartis, please contact:. SVP, Corporate Development.
Versartis, Inc. - VRS-317
http://www.versartis.com/content/productpipeline/vrs-317.htm
Somavaratan is Versartis' investigational, novel, long-acting form of recombinant human growth hormone (rhGH). This fusion protein consists of rhGH and specific sequences of naturally-occurring hydrophilic amino acids based on a proprietary XTEN. Growth hormone deficiency in children and adults. Phase 1 clinical trial in adult patients with growth hormone deficiency (completed). Phase 2 clinical trial in adult patients with growth hormone deficiency (enrollment complete). August 2012, 101 (8): 2744-2754.
Versartis, Inc. - Contact Us
http://www.versartis.com/content/careers/index.htm
At Versartis, we are seeking individuals who share our passion for developing long-acting therapeutic proteins for the treatment of endocrine disorders. If this sounds like a place where you would like to work, click on the link below to learn more about the specific opportunities we have available.
Versartis, Inc. - Senior Management
http://www.versartis.com/content/aboutus/seniormanagement.htm
President and Chief Executive Officer. Joshua T. Brumm. Colin Hislop, MD. Senior Vice President, Corporate Development. Shane M. Ward. Senior Vice President, Legal and Compliance. Bert Bakker, MD, PhD. Senior Vice President, Medical Affairs. Michael Burdick, RAC. Senior Vice President, Regulatory Affairs. George Bright, MD. Vice President, Clinical Development. Vice President, Global Clinical Operations. Vice President, Marketing. Vice President, Manufacturing. Gregory S. Yedinak. Rajendra Mohabir, PhD.
TOTAL PAGES IN THIS WEBSITE
7
Current Partners - Amunix
http://www.amunix.com/partnering/current-partners
Become an Amunix Partner. News & Publications. Amunix believes in the power of partnerships and collaborative efforts, and has a long history of joint research and development projects. Together with our partners, we have advanced the development of novel therapeutics to treat cancer, gastrointestinal diseases, hormone deficiencies, blood disorders, and more. Our established agreements and partnerships include:. Amunix signed a collaboration agreement with Shire to apply XTEN to an undisclosed target.
Investor Overview - Versartis
http://ir.versartis.com/index.cfm
Annual Reports and Proxies. Versartis, Inc. is an endocrine-focused biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders. Versartis was founded in December 2008 and is headquartered in Menlo Park, California, USA. 4:00 PM ET on Nov 9, 2016. Delayed at least 20 minutes. Nov 7, 2016. Versartis Presents Safety, Efficacy and IGF-I Data for Somavaratan in Pediatric Growth Hormone Deficiency at the 2016 Congress of the GRS and IGF Society. Nov 3, 2016.
Key Ratios - Versartis
http://ir.versartis.com/financials-keyratios.cfm
Annual Reports and Proxies.
Corporate Governance - Versartis
http://ir.versartis.com/corporate-governance.cfm
Annual Reports and Proxies. File is in Briefcase. File is in Briefcase. Nominating and Corporate Governance Committee Charter. File is in Briefcase. File is in Briefcase. File is in Briefcase. Add file to Briefcase.
Events & Presentations - Versartis
http://ir.versartis.com/eventdetail.cfm?EventID=160348
Annual Reports and Proxies. Bank of America Merrill Lynch 2015 Health Care Conference. May 13, 2015. Location: Las Vegas, Nevada.
Investment Calculator - Versartis
http://ir.versartis.com/calculator.cfm
Annual Reports and Proxies. Our Investment Calculator is currently not available.
Press Releases - Versartis
http://ir.versartis.com/releases.cfm
Annual Reports and Proxies. Nov 7, 2016. Versartis Presents Safety, Efficacy and IGF-I Data for Somavaratan in Pediatric Growth Hormone Deficiency at the 2016 Congress of the GRS and IGF Society. File is in Briefcase. Nov 3, 2016. Versartis Reports Third Quarter 2016 Financial Results. File is in Briefcase. Oct 31, 2016. Versartis to Present at Two Investor Conferences in November. MENLO PARK, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) - Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biophar...MENLO PAR...
Events & Presentations - Versartis
http://ir.versartis.com/events.cfm
Annual Reports and Proxies. Nov 29, 2016. 28th Annual Piper Jaffray Healthcare Conference. Location: Lotte New York Palace, New York City. 28th Annual Piper Jaffray Healthcare Conference. Please sign up for email alert notification. Nov 7, 2016. Versartis Corporate Presentation - November 2016. File is in Briefcase. Nov 7, 2016. GRS 2016 Dose Increase Data Presentation. File is in Briefcase. Nov 7, 2016. GRS 2016 Safety Poster. File is in Briefcase. Sep 12, 2016. ESPE 2016 Adherence Poster. Sep 12, 2016.
Annual Reports and Proxies - Versartis
http://ir.versartis.com/annuals-proxies.cfm
Annual Reports and Proxies. Annual Reports and Proxies. File is in Briefcase. File is in Briefcase. Apr 12, 2016. File is in Briefcase. Apr 20, 2015. File is in Briefcase. Add file to Briefcase.
SEC Filings - Versartis
http://ir.versartis.com/sec.cfm
Annual Reports and Proxies. All Filings (excluding Section 16). Nov 4, 2016. File is in Briefcase. Nov 3, 2016. File is in Briefcase. Oct 14, 2016. File is in Briefcase. Oct 13, 2016. Brumm, joshua t. File is in Briefcase. Oct 13, 2016. File is in Briefcase. Oct 13, 2016. File is in Briefcase. Oct 13, 2016. File is in Briefcase. Oct 5, 2016. Amended statement of beneficial ownership. File is in Briefcase. Oct 5, 2016. File is in Briefcase. Oct 4, 2016. File is in Briefcase. 10 results per page.
TOTAL LINKS TO THIS WEBSITE
64
Home
Klicken Sie hier um sich für unseren digitalen Kundenordner zu registrieren." data-rel="popover" data-placement="bottom" target=" blank". Klicken Sie hier um sich für unseren digitalen Kundenordner anzumelden." data-rel="popover" data-placement="bottom" target=" blank". Lassen Sie sich kompetent, bedarfsorientiert und zielführend. In allen Fragen rund um Versicherungsfragen beraten. Wir sind Sachwalter unserer Kunden. Ermittlung der Versicherungssumme Wert 1914. Rahmerstr. 20, 40489 Düsseldorf.
Parallels H-Sphere versarte.org
Welcome to versarte.org. Your account has been created. You can access your Web site right away using d8511244.u30.websitesource.net. Over the next few days, DNS servers all across the Internet will update themselves with your new site name. Once that happens, you will be able to access your site at its permanent address, versarte.org. This page is autogenerated by Parallels.
Versar-te | Cursos de História da Arte e outras Poéticas
Web hosting provider - Bluehost.com - domain hosting - PHP Hosting - cheap web hosting - Frontpage Hosting E-Commerce Web Hosting Bluehost
Web Hosting - courtesy of www.bluehost.com.
Domain Expires
This domain name has expired. In order to restore the domain and continue the service you will have to contact your registrar immediately.
Versartis, Inc.
VRS-317 is a novel, long-acting, recombinant human growth hormone, for the treatment of pediatric growth hormone deficiency. The Company has recently initiated a Phase 3 clinical study of VRS-317 in pediatric growth hormone deficient patients. New compounds developed using the XTEN technology are expected to provide improvement in outcomes such as enhanced efficacy, fewer side effects, improved patient adherence and convenience, and enhanced stability.
VersArts - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 4 Years. This deviant's full pageview. Last Visit: 1 week ago. This is the place where you can personalize your profile! Aug 7, 2016.
Domov
VersAuto - Avtomobilska industrija. VersLog - Data loggerji. VersMobile - Prenosni merilni sistem. VersProces - Avtomatizacija procesov. VersVision - Strojni vid. Od informacijskih sistemov nove dobe do različnih varnostnih in strokovnih izdelkov. Vse kar potrebujete je kovček. V njem se nahaja stabilni Real-Time kontroller, superhitri FPGA sistem, baterija, senzorika in 4G povezava z omrežjem. Mitja Gliha, Direktor. ID za DDV: SI53967763.
Protected Blog › Log in
Https:/ versarviver.wordpress.com/. Is marked private by its owner. If you were invited to view this site, please log in. Below Read more about privacy settings. Larr; Back to WordPress.com.
ALBERHOF - Index
Stars and Stripes (39). Herzlich Willkommen in unserem Onlineshop. Walnussöl kaltgepresst 250 ml. ARIAT ProBaby Scotch Oiled Rowdy. 50 - 75 %. By Gambio.de 2012. Sie haben noch keine Artikel in Ihrem Warenkorb.
News About The Middle East, India, Pakistan
Focus on The Middle East and South Asia. From hostage crisis to nuclear deal: prisoner and captor look back at the Iran-US cold war. Disbelief in Mississippi at How Far ISIS’ Message Can Travel. A decade later, Israelis see Gaza pullout as big mistake. ISIS Suspected of Chemical Attack Against Kurds in Syria. Rabaas massacre: The political impact. Shia-Sunni divide growing among British Muslims: Report. Cancer patient ends life at Dignitas in Switzerland. The Globe and Mail. The Globe and Mail. Surfers p...
